• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconOzempic

Ozempic

Page 8 of 9
Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’
Health
Ozempic, Wegovy demand so strong Europe’s most valuable listed company plans ‘mega manufacturing facility’
By Ellie Harmsworth and BloombergDecember 24, 2023
Ozempic manufactured by Novo Nordisk packaging on December 7, 2023.
Health
Novo Nordisk became Europe’s most valuable company with the rise of Wegovy and Ozempic, but it’s facing stiff competition from a local pharma rival
By Christian Wienberg and BloombergDecember 13, 2023
Weight loss drugs are all the rage.
Health
Pfizer rocked by failure of weight-loss pill set to compete with lucrative rivals Ozempic and Mounjaro
By Madison Muller and BloombergDecember 1, 2023
Lars Fruergaard Jorgensen holding a microphone in one hand and paper flashcards in the other hand
Health
Wegovy maker Novo Nordisk could make prices flexible—without cutting them—to persuade more health systems to cover the weight-loss drugs
By Prarthana PrakashNovember 27, 2023
Obesity drugs in Ozempic, Wegovy and Mounjaro are trimming back the Thanksgiving ‘food orgy’
Health
Obesity drugs in Ozempic, Wegovy and Mounjaro are trimming back the Thanksgiving ‘food orgy’
By Jonel Aleccia and The Associated PressNovember 20, 2023
So many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug
Retail
So many Americans are using Novo Nordisk’s blockbuster weight loss-aiding Ozempic that Germany may ban exports of the drug
By Ryan HoggNovember 16, 2023
a box of wegovy injectables
Retail
Scientists have discovered a new benefit to Novo Nordisk’s weight-loss drug Wegovy: It can cut heart-related deaths by 20%, drugmaker reports
By Prarthana PrakashNovember 13, 2023
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
Health
Europe’s most valuable drugmaker Novo Nordisk is threatening the EU with a shift to the U.S.
By Ryan HoggNovember 6, 2023
picture of four wegovy injections lined up
Health
Novo Nordisk isn’t alone: Sales of Ozempic rival Mounjaro explode as drugmaker Eli Lilly profits from Americans’ weight-loss craze
By Prarthana PrakashNovember 3, 2023
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
Health
Brands like Walmart and Nestle are right to worry about Wegovy. Novo Nordisk sold $900m of the weight loss drug last quarter—and 95% was in the U.S.
By Ryan HoggNovember 2, 2023
zoomed-in photo of ozempic drug packaging next to a portrait of a woman smiling
Newsletters
CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid down-sizing’ of consumer business
By Jessica MathewsOctober 31, 2023
zoomed-in photo of ozempic drug packaging next to a portrait of a woman smiling
Finance
Exclusive: CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid downsizing’ of consumer business 
By Jessica MathewsOctober 30, 2023
KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories
Europe
KitKat maker Nestlé working on ‘companion products’ for weight-loss-aiding drugs Ozempic and Wegovy in case shoppers start cutting calories
By Ryan HoggOctober 19, 2023
Eli Lilly
Health
New weight-loss blockbuster drug emerges from study showing Mounjaro helps people lose 25% of their body weight or 60 pounds on average
By Jonel Aleccia and The Associated PressOctober 15, 2023
Pepsico CEO Ramon Laguarta
Companies
Pepsi’s CEO is keeping an eye on weight-loss drugs, but shakes off fears voiced by Walmart that they could hurt the bottom line
By Christiaan HetznerOctober 11, 2023
1...
  • 5
  • 6
  • 7
  • 8
  • 9
9
Most Popular
Big Tech
As Big Tech showers employees with perks to win the talent war, Nvidia built a nearly $5 trillion company by making people pay for their own lunchplaceholder alt text
By Marco Quiroz-GutierrezJuly 1, 2026
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last yearplaceholder alt text
By Sydney LakeJune 25, 2026
Newsletters
The Supreme Court's birthright citizenship ruling hands the U.S. economy a $7.7 trillion winplaceholder alt text
By Diane BradyJuly 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.